Hamish Corlett joins the Board of QBiotics

9 April 2021

Mr Hamish Corlett joined the Board of QBiotics Group Limited (QBiotics) as a Non-Executive Director on 9 April 2021. Hamish is a Co-Founder and Partner at TDM Growth Partners, a private investments firm specialising in high growth companies globally. Hamish brings more than 20 years’ experience in investing and investment banking, from multiple top-tier investment firms, to his role on the QBiotics Board.

Hamish is currently a Non-Executive Director of Somnomed Limited (ASX:SOM), a medical company providing treatment solutions for sleep-related breathing disorders. He is also Chair of Somnomed’s Remuneration Committee. Hamish has also been a Non-Executive Director of Tyro Payments Ltd (ASX:TYR) since April 2019.

Hamish holds a Bachelor of Commerce with Honours Class 1 (Accounting and Finance) from the University of Sydney and a Graduate Diploma of Counselling from the Australian College of Applied Psychologists.

QBiotics is pleased to welcome Hamish Corlett to the Board of Directors, and we look forward to working with him on the next phase of the company’s growth.